Zynex announces additional share buyback program

Englewood, colo. , nov. 1, 2022 /prnewswire/ -- zynex, inc. (nasdaq: zyxi), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that its board of directors approved a program to buy back $10.0 million of the company's common stock.
ZYXI Ratings Summary
ZYXI Quant Ranking